CYP2D6 genotyping and use of antidepressants in breast cancer patients: test development for clinical application
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1573-7365
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
CYP2D6 genotyping and use of antidepressants in breast cancer patients: test development for clinical application ; volume:27 ; number:3 ; day:26 ; month:5 ; year:2012 ; pages:319-326 ; date:9.2012
Metabolic brain disease ; 27, Heft 3 (26.5.2012), 319-326, 9.2012
- Creator
-
van der Merwe, Nicole
Bouwens, Christianne S. H.
Pienaar, Rika
van der Merwe, Lize
Yako, Yandiswa Y.
Geiger, Dieter H.
Kotze, Maritha J.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s11011-012-9312-z
- URN
-
urn:nbn:de:101:1-2021082808183910594714
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:50 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- van der Merwe, Nicole
- Bouwens, Christianne S. H.
- Pienaar, Rika
- van der Merwe, Lize
- Yako, Yandiswa Y.
- Geiger, Dieter H.
- Kotze, Maritha J.
- SpringerLink (Online service)
Other Objects (12)
Cyrius: accurate CYP2D6 genotyping using whole-genome sequencing data
Allele Drop Out Conferred by a Frequent CYP2D6 Genetic Variation For Commonly Used CYP2D6*3 Genotyping Assays
Publisher Correction: Cyrius: accurate CYP2D6 genotyping using whole-genome sequencing data
Multiplex SNaPshot—a new simple and efficient CYP2D6 and ADRB1 genotyping method
Antidepressants
Effect of CYP2D6 pharmacogenetic phenotype and phenoconversion on serum concentrations of antidepressants and antipsychotics: a retrospective cohort study
Limited predictive value of achieving beneficial plasma (Z)-endoxifen threshold level by CYP2D6 genotyping in tamoxifen-treated Polish women with breast cancer
Co-prescription of metoprolol and CYP2D6-inhibiting antidepressants before and after implementation of an optimized drug interaction database in Norway
Influence of CYP2D6 genotype on tamoxifen efficacy in advanced breast cancer
Antidepressants and age
Antidepressants and Age
Overcoming CYP2D6-mediated tamoxifen resistance in postmenopausal breast cancer : a PBPK approach
Cyrius: accurate CYP2D6 genotyping using whole-genome sequencing data
Allele Drop Out Conferred by a Frequent CYP2D6 Genetic Variation For Commonly Used CYP2D6*3 Genotyping Assays
Publisher Correction: Cyrius: accurate CYP2D6 genotyping using whole-genome sequencing data
Multiplex SNaPshot—a new simple and efficient CYP2D6 and ADRB1 genotyping method
Antidepressants
Effect of CYP2D6 pharmacogenetic phenotype and phenoconversion on serum concentrations of antidepressants and antipsychotics: a retrospective cohort study
Limited predictive value of achieving beneficial plasma (Z)-endoxifen threshold level by CYP2D6 genotyping in tamoxifen-treated Polish women with breast cancer
Co-prescription of metoprolol and CYP2D6-inhibiting antidepressants before and after implementation of an optimized drug interaction database in Norway
Influence of CYP2D6 genotype on tamoxifen efficacy in advanced breast cancer
Antidepressants and age
Antidepressants and Age
Overcoming CYP2D6-mediated tamoxifen resistance in postmenopausal breast cancer : a PBPK approach
Cyrius: accurate CYP2D6 genotyping using whole-genome sequencing data
Allele Drop Out Conferred by a Frequent CYP2D6 Genetic Variation For Commonly Used CYP2D6*3 Genotyping Assays
Publisher Correction: Cyrius: accurate CYP2D6 genotyping using whole-genome sequencing data
Multiplex SNaPshot—a new simple and efficient CYP2D6 and ADRB1 genotyping method
Antidepressants
Effect of CYP2D6 pharmacogenetic phenotype and phenoconversion on serum concentrations of antidepressants and antipsychotics: a retrospective cohort study
Limited predictive value of achieving beneficial plasma (Z)-endoxifen threshold level by CYP2D6 genotyping in tamoxifen-treated Polish women with breast cancer
Co-prescription of metoprolol and CYP2D6-inhibiting antidepressants before and after implementation of an optimized drug interaction database in Norway
Influence of CYP2D6 genotype on tamoxifen efficacy in advanced breast cancer
Antidepressants and age
Antidepressants and Age